MedPath

A double blind randomised controlled trial assessing the effect of 30% topical lidocaine gel on reducing pain in patients presenting to a cosmetic surgery practice with either prominent periorbital or lateral temporal veins for treatment with Neodymium-Doped Yttrium Aluminum Garnet (ND:TAG))

Phase 4
Completed
Conditions
Surgery - Surgical techniques
Periorbital and lateral temporal veins - cosmetic
Registration Number
ACTRN12613000996763
Lead Sponsor
niversity of Toronto
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

1. 18 years of age or older
2. Cosmetically significant lateral temporal or infra-orbital as subjectively judged by the patient

Exclusion Criteria

1. known sensitivity or allergy to any topical or other anaesthetic medication
2. unilateral veins only

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath